(July 30, 2019, 1:22 PM EDT) -- SAN FRANCISCO — The California Attorney General’s Office on July 29 announced that drug maker Teva Pharmaceutical Industries Ltd. will pay $69 million to settle allegations that it entered into pay-to-delay agreements to keep competing generic versions of the sleep drug Provigil off the market and to maintain a monopoly....